Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer have?

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has 987 citations in the OpenAlex counts ScholarIQ stores.

When was Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer published?

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has 2018 year in the ScholarIQ index.

What is the open-access status of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?

The DOI for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?

The PMID for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer?

The OpenAlex for Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer is on the source record.